Together they have been working on the FRONTS project an NSF EFRI (Emerging Frontiers in Research and Innovation.) FRONTS is the acronym for Flexible Resorbable Organic Nanomaterial Therapeutic Systems. In part two of our interview we discuss the ethical quandaries of bioengineering and the experience of moving research into a startup company.
Friday, February 7th @ noon, Spectrum presents part two of two interviews with Michel M. Maharbiz and Daniel Cohen. Michel is an associate professor with the Department of Electrical Engineering and Computer Science at UC Berkeley. His current research interests include building micro/nano interfaces to cells and organisms and exploring bio-derived fabrication methods. Daniel Cohen received his PhD from the joint UC Berkeley and UCSF Department of Bioengineering program in 2013.